Virion Therapeutics Unveils Promising HBV Treatment at CROI Conference Is the global fight against chronic hepatitis B (CHB) finally turning a corner? Virion Therapeutics, LLC, a clinical-stage biotechnology company, is making significant strides with its novel T cell-based immunotherapy, VRON-0200.…
Exact Sciences Corporation Gains Overwhelming Shareholder Support for Abbott Deal In the rapidly evolving landscape of cancer diagnostics, where precision and speed are paramount, Exact Sciences Corporation has taken a significant step forward. The company, a leading provider of cancer…
Pulse Biosciences Awards Equity to New Hires to Drive Growth and Innovation In the competitive landscape of biotechnology, where innovation and talent retention are paramount, Pulse Biosciences, Inc. stands out as a leader in bioelectric medicine. The company, known for…
Science and Neurosoft Team Up to Reduce BCI Development Costs and Time Science Corporation, a pioneering full-stack neural engineering company, and Neurosoft Bioelectronics, a neural data company, have announced a strategic partnership to grant Neurosoft access to Science’s full stack…
Union President Demands Premier Houston to Invest in Public Services Why is the Nova Scotia government prioritizing private contracts over public service workers? CUPE Nova Scotia, a union representing long-term care workers, is demanding Premier Tim Houston to offer a…
ALIS Unveils Comprehensive Clinical and Operational Insights for Senior Living Communities In an industry where data-driven decisions can mean the difference between thriving and merely surviving, ALIS is setting a new standard. The leading senior living intelligent eHR software company…
WestFax Launches AI-Powered Intelligent Document Processing Platform for Healthcare WestFax, a provider of HIPAA-compliant cloud fax and healthcare document exchange solutions, today announced the official launch of WestFax Comprehend, an AI-powered Intelligent Document Processing (IDP) platform designed to automate medical…
Savara Announces the U.S. Food and Drug Administration (FDA) Filed the MOLBREEVI* Biologics License Application (BLA) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) Savara Inc. a clinical-stage biopharmaceutical company focused on rare respiratory diseases, announced the FDA has filed for…
Agenus Presents Biomarker Data Demonstrating Survival Stratification in MSS mCRC and Other Immunologically Cold Tumors Treated with BOT+BAL Agenus Inc. a leader in immuno-oncology, today announced new translational and clinical biomarker data from its Phase 1b C-800-01 trial (NCT03860272) evaluating…
Animate Biosciences Reports Preclinical Data Showing Dramatic Reduction in Cardiac Scarring and Near-Doubling of Heart Function After Experimental Heart Attack Animate Biosciences, a biotechnology company focused on designing innovative peptide therapeutics, today announces positive preclinical results demonstrating that its lead…
PureTech Announces Orphan Drug Designations Granted by the U.S. Food and Drug Administration and European Commission for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis PureTech Health plc a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value,…
Atrandi Biosciences Redefines Single-Cell Multiomics with Expanded SPC Innovator Kit Portfolio Atrandi Biosciences, a life sciences tools company advancing single-cell analysis, today announced the launch of its new 170 µm and 300 µm SPC Innovator Kits, the company’s most versatile SPC…